Centre provides over 24.60 crore COVID vaccine doses to States, UTs

The central government provided more than 24 crore COVID-19 vaccine doses to states so far, said the Ministry of Health and Family Welfare (MoHFW) on Sunday.

coronavirus vaccine, gst, gst on vaccine, covid-19
ANI General News
2 min read Last Updated : Jun 06 2021 | 3:51 PM IST

The central government provided more than 24 crore COVID-19 vaccine doses to states so far, said the Ministry of Health and Family Welfare (MoHFW) on Sunday.

According to the Union Home Ministry, the Centre has provided 24,60,80,900 doses of COVID vaccines to States/UTs, both through the free of cost category and through the direct state procurement category.

"Of this, the total consumption, including wastages is 22,96,95,199 doses. More than 1.63 crore COVID vaccine doses (1,63,85,701) are still available with the States/UTs to be administered," reads the statement issued by the MoHFW.

The implementation of the "Liberalized and Accelerated Phase-III Strategy of COVID-19 Vaccination" has started on May 1, 2021.

Under the Strategy, every month 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by the central government.

India reported 1,14,460 new COVID-19 cases, 1,89,232 discharges, and 2,677 deaths in the last 24 hours, informed the Union Health Ministry on Sunday.

This is the lowest number of cases reported in the last two months. On April 5,96,982 cases were reported. The following day, 1,15,736 new cases were reported.

A total of 2,88,09,339 positive cases have been reported so far, including 2,69,84,781 recoveries, and 14,77,799 active cases.

The national recovery rate has increased to 93.67 per cent. The weekly positivity rate, meanwhile, stands at 6.54 per cent. As many as 23,13,22,417 doses of the COVID-19 vaccine have been administered so far.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Jun 06 2021 | 3:50 PM IST

Next Story